Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke "DIAS-3"

Completed

Phase 3 Results N/A

Summary of Purpose

The purpose of the study is to determine whether desmoteplase is effective and safe in the treatment of patients with acute ischaemic stroke when given within 3-9 hours from onset of stroke symptoms.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 September 2015.

1 Dec 2008 13 Nov 2008 1 Jul 2014 Unavailable 1 Sep 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Email contact via H. Lundbeck A/S